Connect with us

Hi, what are you looking for?

Investing

Black Mountain Phase 2 Program has Commenced

Chariot Corporation (CC9:AU) has announced Black Mountain Phase 2 Program has Commenced Download the PDF here. This post appeared first on investingnews.com

4 hours ago

Investing

Radiopharm achieves Nasdaq listing of ADS

Radiopharm Theranostics (RAD:AU) has announced Radiopharm achieves Nasdaq listing of ADS Download the PDF here. This post appeared first on investingnews.com

4 hours ago

Investing

Impact Minerals Limited

Overview Impact Minerals (ASX:IPT) is an exploration and development mining company focused on discovering and developing new resource projects within Australia. Lake Hope, a...

April 19, 2024

Investing

Biotech Market Update: Q1 2024 in Review

The first quarter of 2024 witnessed a surge in initial public offerings (IPOs) and mergers and acquisitions (M&A) within the biotech industry, signaling continued...

April 19, 2024

Investing

Cardiex Limited

Overview Cardiex Limited (ASX:CDX) is an ASX-listed medical technology company leveraging its proprietary SphygmoCor® technology to develop and market vascular biomarker technologies and digital...

April 19, 2024
More Posts
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Dealwithbiz.com